Indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and
bacteria (coagulase positive staphylococci, Pseudomonas aeruginosa and Enterococcus faecalis). Posaconazole: Novel triazole
antifungal, new to animal health, Particularly effective against Malassezia pachydermatis, More potent than other veterinary
antifungals. Orbifloxacin: Broad spectrum antibiotic, Proven efficacy against bacteria associated with canine otitis externa
including Pseudomonas aeruginosa, High local concentrations minimize risk of microbial resistance. Mometasone furoate monohydrate:
Potent anti-inflammatory agent, Good margin of adrenal safety, No adrenocortical suppression at 3 times recommended dose for 21
days.